Comparing treatment strategies for managing gout symptoms and serum urate levels
Official title: Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)
Funded at Massachusetts General Hospital · NIH-10917026 · Data updated 2026-11-12
This study is looking at two ways to help people with gout: one that tries to lower uric acid levels in the blood and another that focuses on easing pain and other symptoms, so if you have gout, you can help us find out which method works better for your health!
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,937,050 |
| NIH project number | 5U01AR080985-02 |
| Project ID | NIH-10917026 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have been diagnosed with gout.
✕Less likely to help
Patients who do not have gout or those with other unrelated health conditions may not benefit from this research.
What this research studies
This research investigates two different approaches to treating gout: one that aims to lower serum urate levels to a specific target and another that focuses on alleviating symptoms. By conducting a randomized controlled trial, the study will involve collaboration between rheumatologists and primary care providers to gather high-level evidence on the effectiveness of these strategies. Patients will be monitored for changes in their gout symptoms and overall health outcomes, including potential impacts on kidney function and cardiovascular health. The goal is to provide clearer guidelines for gout management based on solid evidence.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for gout, improving patient outcomes and quality of life.
How similar studies have gone: Previous research has shown that targeting serum urate levels can be beneficial in managing gout, but this specific comparative approach is relatively novel.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Choi, Hyon K — Massachusetts General Hospital
- Study coordinator: Choi, Hyon K
Related research
Other NIH-funded projects on the same topics.
-
Treat-to-Target Urate in Gout: A New Approach for Better Pain and Health
A large clinical trial tests whether aiming for a specific uric acid level in gout patients improves symptoms and health outcomes compared with avoiding symptoms.
-
SGLT2 inhibitors for gout care in adults with diabetes
A randomized trial is testing whether an SGLT2 inhibitor can help reduce gout flares and improve heart and kidney health in adults with type 2 diabetes.
-
Targeting low blood uric acid versus treating gout flares for adults with gout
This compares keeping blood uric acid below a set level versus treating gout flares only, for adults living with gout.
-
Using SGLT2 inhibitors to improve gout care
This study is looking at whether a type of medication called SGLT2 inhibitors can help people with gout feel better and reduce their risk of heart problems, and it’s for adults who experience gout flare-ups.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.